PREVNAR 20: payments to doctors
Payments that named PREVNAR 20 as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $5.8M
- Providers
- 75,790
- Transactions
- 228,970
- Average per transaction
- $26
The per-transaction average — $26 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 75,790 providers the average total is $77, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Pfizer | $5,827,587 | 99.8% |
| PBG Puerto RICO LLC | $11,483 | 0.2% |
| Array Biopharma Inc | $299 | 0.0% |